Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The third international conference on AIDS last week was as much politics as science. But politicians are proving to be inept at putting their weight where most good would be done.
The Rockefeller Foundation of New York is seeking new ways of adapting science to the needs of the world's poorest nations. Its problem is that technology is necessary but not sufficient for improvement.
The long incubation period between infection and the development of clinical AIDS may be due to an immune response to the initial infection which persists with health and wanes with disease. If this response can be boosted, it may be possible to reduce the viral burden, prevent the development of disease and reduce contagiousness.
Next week, exhibitors from all over Europe will converge on Amsterdam, the Netherlands, for the 4th European Congress on Biotechnology, ready to show off their bioreactors, chromatographs, and products for molecular biology.
